L Boldrini
Overview
Explore the profile of L Boldrini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
755
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dinapoli L, Dinapoli N, Marconi E, Chiesa S, Mazzarella C, Massaccesi M, et al.
Strahlenther Onkol
. 2025 Mar;
PMID: 40047896
Purpose: Recent studies indicate that gender plays a role in influencing the side effects and outcomes of radiotherapy (RT), thus highlighting the importance of gender-specific clinical approaches. However, there remains...
2.
Meldolesi E, Nicoli A, Dinapoli N, Chiloiro G, Romano A, Menghi R, et al.
Clin Transl Radiat Oncol
. 2025 Jan;
51:100905.
PMID: 39886541
Purpose//objectives: A disproportionate incidence's increase of rectal cancer in patients younger than 50 years of age. The ESMO and NCCN recommendations are not age-specific and the literature is poor and...
3.
Valenza C, Mongillo M, Gigli F, Trapani D, Katrini J, Nicolo E, et al.
ESMO Open
. 2024 Aug;
9(9):103685.
PMID: 39214046
Background: Among patients with advanced high-grade ovarian carcinoma (aHGOC) treated with poly (ADP-ribose) polymerase (PARP) inhibitors (PARPis), the presence of a germline BRCA pathogenic variant (gBRCA-PV) may increase the risk...
4.
Moro F, Vagni M, Tran H, Bernardini F, Mascilini F, Ciccarone F, et al.
Ultrasound Obstet Gynecol
. 2024 May;
65(3):353-363.
PMID: 38748935
Objective: The primary aim was to identify radiomics ultrasound features that can distinguish between benign and malignant adnexal masses with solid ultrasound morphology, and between primary malignant (including borderline and...
5.
Russo L, Charles-Davies D, Bottazzi S, Sala E, Boldrini L
Clin Oncol (R Coll Radiol)
. 2024 Mar;
36(8):e269-e281.
PMID: 38548581
Radiomics is a promising tool for the development of quantitative biomarkers to support clinical decision-making. It has been shown to improve the prediction of response to treatment and outcome in...
6.
Di Pilla A, Nero C, Specchia M, Ciccarone F, Boldrini L, Lenkowicz J, et al.
Sci Rep
. 2024 Jan;
14(1):928.
PMID: 38195911
Current approach to identify BRCA 1/2 carriers in the general population is ineffective as most of the carriers remain undiagnosed. Radiomics is an emerging tool for large scale quantitative analysis...
7.
Chiesa S, Russo R, Beghella Bartoli F, Palumbo I, Sabatino G, Cannata M, et al.
Front Med (Lausanne)
. 2023 Feb;
10:1059712.
PMID: 36744131
Background: The glioblastoma's bad prognosis is primarily due to intra-tumor heterogeneity, demonstrated from several studies that collected molecular biology, cytogenetic data and more recently radiomic features for a better prognostic...
8.
Moro F, Boldrini L, Lenkowicz J, Scambia G, Testa A, Fanfani F
Ultrasound Obstet Gynecol
. 2022 Aug;
60(2):299-300.
PMID: 35913380
No abstract available.
9.
Iezzi R, Casa C, Posa A, Cornacchione P, Carchesio F, Boldrini L, et al.
Eur Rev Med Pharmacol Sci
. 2022 May;
26(8):2891-2899.
PMID: 35503635
Objective: The objective of this study is to find a contrast-enhanced CT-radiomic signature to predict clinical incomplete response in patients affected by hepatocellular carcinoma who underwent locoregional treatments. Patients And...
10.
Placidi L, Cusumano D, Alparone A, Boldrini L, Nardini M, Meffe G, et al.
Phys Med
. 2021 Nov;
91:80-86.
PMID: 34739878
Purpose: The unique treatment delivery technique provided by magnetic resonance guided radiotherapy (MRgRT) can represent a significant drawback when system fail occurs. This retrospective study proposes and evaluates a pipeline...